Muscle-Sparing Biologic
Muscle loss during GLP-1 mediated weight loss
DiscoveryActive
Key Facts
Indication
Muscle loss during GLP-1 mediated weight loss
Phase
Discovery
Status
Active
Company
About Aequita Bioworks
Founded in 2021 and based in Cambridge, USA, Aequita Bioworks is a private, pre-revenue biotech company with a dual focus on diagnostics and therapeutics. Its core offering is a proprietary, automated platform that accelerates critical quality control assays, beginning with rapid sterility testing for the compounding pharmacy market. Led by a team with backgrounds in AI, biotech research, and operations, the company is leveraging its platform to develop additional assay products and a novel biologic aimed at mitigating muscle loss during GLP-1 weight loss therapy.
View full company profile